NM_003859.3:c.679-7_679-6insT

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1

The NM_003859.3(DPM1):​c.679-7_679-6insT variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0256 in 1,541,218 control chromosomes in the GnomAD database, including 1,645 homozygotes. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.10 ( 1377 hom., cov: 29)
Exomes 𝑓: 0.019 ( 268 hom. )

Consequence

DPM1
NM_003859.3 splice_region, intron

Scores

Not classified

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -0.0770

Publications

3 publications found
Variant links:
Genes affected
DPM1 (HGNC:3005): (dolichyl-phosphate mannosyltransferase subunit 1, catalytic) Dolichol-phosphate mannose (Dol-P-Man) serves as a donor of mannosyl residues on the lumenal side of the endoplasmic reticulum (ER). Lack of Dol-P-Man results in defective surface expression of GPI-anchored proteins. Dol-P-Man is synthesized from GDP-mannose and dolichol-phosphate on the cytosolic side of the ER by the enzyme dolichyl-phosphate mannosyltransferase. Human DPM1 lacks a carboxy-terminal transmembrane domain and signal sequence and is regulated by DPM2. Mutations in this gene are associated with congenital disorder of glycosylation type Ie. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2015]
ADNP-AS1 (HGNC:51227): (ADNP antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP6
Variant 20-50935242-T-TA is Benign according to our data. Variant chr20-50935242-T-TA is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 338752.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.357 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DPM1NM_003859.3 linkc.679-7_679-6insT splice_region_variant, intron_variant Intron 8 of 8 ENST00000371588.10 NP_003850.1 O60762A0A0S2Z4Y5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DPM1ENST00000371588.10 linkc.679-7_679-6insT splice_region_variant, intron_variant Intron 8 of 8 1 NM_003859.3 ENSP00000360644.5 O60762

Frequencies

GnomAD3 genomes
AF:
0.102
AC:
12651
AN:
124268
Hom.:
1369
Cov.:
29
show subpopulations
Gnomad AFR
AF:
0.363
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0472
Gnomad ASJ
AF:
0.0501
Gnomad EAS
AF:
0.0292
Gnomad SAS
AF:
0.0360
Gnomad FIN
AF:
0.0172
Gnomad MID
AF:
0.0360
Gnomad NFE
AF:
0.0183
Gnomad OTH
AF:
0.0831
GnomAD2 exomes
AF:
0.0298
AC:
7020
AN:
235258
AF XY:
0.0263
show subpopulations
Gnomad AFR exome
AF:
0.236
Gnomad AMR exome
AF:
0.0222
Gnomad ASJ exome
AF:
0.0394
Gnomad EAS exome
AF:
0.0251
Gnomad FIN exome
AF:
0.0106
Gnomad NFE exome
AF:
0.0132
Gnomad OTH exome
AF:
0.0219
GnomAD4 exome
AF:
0.0189
AC:
26737
AN:
1416894
Hom.:
268
Cov.:
21
AF XY:
0.0184
AC XY:
13012
AN XY:
707286
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.215
AC:
6501
AN:
30266
American (AMR)
AF:
0.0238
AC:
1028
AN:
43224
Ashkenazi Jewish (ASJ)
AF:
0.0381
AC:
968
AN:
25438
East Asian (EAS)
AF:
0.0170
AC:
669
AN:
39238
South Asian (SAS)
AF:
0.0226
AC:
1898
AN:
83828
European-Finnish (FIN)
AF:
0.0102
AC:
540
AN:
53160
Middle Eastern (MID)
AF:
0.0213
AC:
118
AN:
5548
European-Non Finnish (NFE)
AF:
0.0122
AC:
13112
AN:
1077508
Other (OTH)
AF:
0.0324
AC:
1903
AN:
58684
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.388
Heterozygous variant carriers
0
1053
2106
3159
4212
5265
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
600
1200
1800
2400
3000
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.102
AC:
12678
AN:
124324
Hom.:
1377
Cov.:
29
AF XY:
0.0991
AC XY:
6013
AN XY:
60704
show subpopulations
African (AFR)
AF:
0.363
AC:
10233
AN:
28202
American (AMR)
AF:
0.0471
AC:
607
AN:
12882
Ashkenazi Jewish (ASJ)
AF:
0.0501
AC:
156
AN:
3112
East Asian (EAS)
AF:
0.0293
AC:
132
AN:
4512
South Asian (SAS)
AF:
0.0355
AC:
155
AN:
4362
European-Finnish (FIN)
AF:
0.0172
AC:
149
AN:
8670
Middle Eastern (MID)
AF:
0.0379
AC:
10
AN:
264
European-Non Finnish (NFE)
AF:
0.0182
AC:
1090
AN:
59752
Other (OTH)
AF:
0.0828
AC:
146
AN:
1764
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
474
947
1421
1894
2368
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
128
256
384
512
640
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0143
Hom.:
2

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Dec 30, 2016
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Congenital disorder of glycosylation Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Congenital disorder of glycosylation type 1E Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
-0.077
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11480415; hg19: chr20-49551779; COSMIC: COSV65373423; COSMIC: COSV65373423; API